Orion Office REIT Inc. (ONL)
NYSE: ONL · Real-Time Price · USD
3.750
-0.110 (-2.85%)
Dec 27, 2024, 4:00 PM EST - Market closed

Orion Office REIT Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Orion Office REIT.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for ONL is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 000000
Buy 000000
Hold 111111
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JMP Securities
JMP Securities
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Jun 11, 2024
EF Hutton
EF Hutton
Strong Buy
Maintains
$10$8
Strong Buy Maintains $10$8 +113.33% May 10, 2023
EF Hutton
EF Hutton
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +166.67% Mar 10, 2023
EF Hutton
EF Hutton
Strong Buy
Maintains
$13$10
Strong Buy Maintains $13$10 +166.67% Mar 9, 2023
EF Hutton
EF Hutton
Strong Buy
Maintains
$15$13
Strong Buy Maintains $15$13 +246.67% Dec 5, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
from -1.02
EPS Next Year
n/a
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023
Revenue
-----
Revenue Growth
-2.19%0.02%49.00%160.55%-6.26%
EPS
0.27-0.03-0.84-1.72-1.02
EPS Growth
-----
Forward PE
-----
No. Analysts -----
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.